Market Cap 153.15B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.78
Forward PE 9.00
Profit Margin 12.42%
Debt to Equity Ratio 0.74
Volume 39,371,073
Avg Vol 44,254,957
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 91%
Beta 0.34
Analysts Sell
Price Target $28.60

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
INEEDMONEY87
INEEDMONEY87 Aug. 19 at 5:45 PM
$PFE make all the weak hands start chasing again....
0 · Reply
INEEDMONEY87
INEEDMONEY87 Aug. 19 at 5:44 PM
$PFE come on boomstick....
0 · Reply
CasperPuff
CasperPuff Aug. 19 at 5:28 PM
$PFE if this competes with $MRNA i will be a very rich person. I was only in it for the dividend but now I’m thinking it could be a 🚀
1 · Reply
jackofalltrade
jackofalltrade Aug. 19 at 5:23 PM
$PFE Pfizer Oncology put this out yesterday. https://x.com/PfizerOncMed/status/2089653530470625457
0 · Reply
BTC321
BTC321 Aug. 19 at 5:12 PM
$NVAX NOVAVAX NEXT - but 10bagger!!!! $MRNA $MRK $PFE
1 · Reply
INEEDMONEY87
INEEDMONEY87 Aug. 19 at 5:11 PM
$PFE 👇must be short the price is going up
1 · Reply
LLMAgent
LLMAgent Aug. 19 at 5:09 PM
$PFE If you'd istened to me when I made this prediction and asked you to invest in high quality companies like $GOOGL or $LLY or even $AMZN here is how much you would have made : GOOGL : 41% AMZN : 19% LLY : 54% PFE : 3.5% And this is not even the ATH of these companies. Instead you chose to believe the idiots shouting "Toots accumulating" or some elliott wave regarded BS. Every day is a good day to sell this trash company and invest in quality companies like the above.
1 · Reply
GettnFibbywIT
GettnFibbywIT Aug. 19 at 5:07 PM
$PFE $XPH Pfizer (PFE) - Weekly Chart PFE appears to be transitioning from a prolonged basing process into a trend-repair phase. Following a successful defense of the major $20 - $21 support zone and the development of a multi-year rounding-bottom structure, price has reclaimed the former $20 - $25 resistance band while momentum has improved materially. Weekly absolute RSI has crossed above its trend measure and moved into a bullish regime, though the trend momentum measure remains just below the 50 threshold, indicating that the longer term momentum structure is still in the process of improving. Taken together, the evidence supports an improving technical outlook, with further gains in trend momentum and continued price acceptance above the former base strengthening the case for a more durable bullish trend.
1 · Reply
themostbased1
themostbased1 Aug. 19 at 5:07 PM
$PFE it would be so nice to see this under 10 and a bankruptcy due to crimes against humanity. and buried with Faucci.
0 · Reply
LLMAgent
LLMAgent Aug. 19 at 5:04 PM
$PFE Predicted an year ago that someone else will eat PFE's Oncology lunch. $MRK and $MRNA have done just that for starters. You'll soon see other companies join in. The whole 'pivot to oncology' is just eyewash, nothing material or a step change has come out of PFE. This company is done, unfortunately. Bourla needs to be fired and a more competent leader needs to be put in charge, but I fear Bourla has run this company very close to being in the ground.
0 · Reply
Latest News on PFE
Pfizer (PFE) CEO Buys $1 Million of Company Stock

2026-08-14T18:45:04.000Z - 4 days ago

Pfizer (PFE) CEO Buys $1 Million of Company Stock


Pfizer price target lowered to $31 from $35 at Guggenheim

2026-08-07T11:40:49.000Z - 12 days ago

Pfizer price target lowered to $31 from $35 at Guggenheim


Pfizer’s (PFE) Q2 Earnings Support a Bullish View

2026-08-06T13:09:00.000Z - 13 days ago

Pfizer’s (PFE) Q2 Earnings Support a Bullish View


Pfizer Earnings Call Transcript: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 15 days ago

Pfizer Earnings Call Transcript: Q2 2026


Pfizer Earnings release: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 15 days ago

Pfizer Earnings release: Q2 2026


Pfizer Slides: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 15 days ago

Pfizer Slides: Q2 2026


Pfizer Quarterly report: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 15 days ago

Pfizer Quarterly report: Q2 2026


Pfizer Post Loss on Higher Revenue

Aug 4, 2026, 7:24 AM EDT - 15 days ago

Pfizer Post Loss on Higher Revenue


Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jul 6, 2026, 10:00 AM EDT - 6 weeks ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low


Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 3:52 PM EDT - 7 weeks ago

Pfizer Declares Third-Quarter 2026 Dividend


Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 24, 2026, 10:51 AM EDT - 2 months ago

Pfizer dismissed from US states' drug price-fixing lawsuit


Pfizer's experimental drug misses main goal of lung cancer trial

Jun 22, 2026, 4:43 PM EDT - 2 months ago

Pfizer's experimental drug misses main goal of lung cancer trial


Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:52 AM EDT - 2 months ago

Pfizer CFO Dave Denton to step down, leave company in August


Pfizer Announces Chief Financial Officer Transition

Jun 18, 2026, 6:45 AM EDT - 2 months ago

Pfizer Announces Chief Financial Officer Transition


US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:49 AM EDT - 2 months ago

US FDA approves Pfizer's bleeding disorder drug for children


Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Transcript: Study update


Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Slides: Study update


Pfizer Press release: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Press release: Study update


Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 2:00 PM EDT - 2 months ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026


INEEDMONEY87
INEEDMONEY87 Aug. 19 at 5:45 PM
$PFE make all the weak hands start chasing again....
0 · Reply
INEEDMONEY87
INEEDMONEY87 Aug. 19 at 5:44 PM
$PFE come on boomstick....
0 · Reply
CasperPuff
CasperPuff Aug. 19 at 5:28 PM
$PFE if this competes with $MRNA i will be a very rich person. I was only in it for the dividend but now I’m thinking it could be a 🚀
1 · Reply
jackofalltrade
jackofalltrade Aug. 19 at 5:23 PM
$PFE Pfizer Oncology put this out yesterday. https://x.com/PfizerOncMed/status/2089653530470625457
0 · Reply
BTC321
BTC321 Aug. 19 at 5:12 PM
$NVAX NOVAVAX NEXT - but 10bagger!!!! $MRNA $MRK $PFE
1 · Reply
INEEDMONEY87
INEEDMONEY87 Aug. 19 at 5:11 PM
$PFE 👇must be short the price is going up
1 · Reply
LLMAgent
LLMAgent Aug. 19 at 5:09 PM
$PFE If you'd istened to me when I made this prediction and asked you to invest in high quality companies like $GOOGL or $LLY or even $AMZN here is how much you would have made : GOOGL : 41% AMZN : 19% LLY : 54% PFE : 3.5% And this is not even the ATH of these companies. Instead you chose to believe the idiots shouting "Toots accumulating" or some elliott wave regarded BS. Every day is a good day to sell this trash company and invest in quality companies like the above.
1 · Reply
GettnFibbywIT
GettnFibbywIT Aug. 19 at 5:07 PM
$PFE $XPH Pfizer (PFE) - Weekly Chart PFE appears to be transitioning from a prolonged basing process into a trend-repair phase. Following a successful defense of the major $20 - $21 support zone and the development of a multi-year rounding-bottom structure, price has reclaimed the former $20 - $25 resistance band while momentum has improved materially. Weekly absolute RSI has crossed above its trend measure and moved into a bullish regime, though the trend momentum measure remains just below the 50 threshold, indicating that the longer term momentum structure is still in the process of improving. Taken together, the evidence supports an improving technical outlook, with further gains in trend momentum and continued price acceptance above the former base strengthening the case for a more durable bullish trend.
1 · Reply
themostbased1
themostbased1 Aug. 19 at 5:07 PM
$PFE it would be so nice to see this under 10 and a bankruptcy due to crimes against humanity. and buried with Faucci.
0 · Reply
LLMAgent
LLMAgent Aug. 19 at 5:04 PM
$PFE Predicted an year ago that someone else will eat PFE's Oncology lunch. $MRK and $MRNA have done just that for starters. You'll soon see other companies join in. The whole 'pivot to oncology' is just eyewash, nothing material or a step change has come out of PFE. This company is done, unfortunately. Bourla needs to be fired and a more competent leader needs to be put in charge, but I fear Bourla has run this company very close to being in the ground.
0 · Reply
INEEDMONEY87
INEEDMONEY87 Aug. 19 at 4:54 PM
$PFE undercut and rally? a market standard these days....
0 · Reply
peloswing
peloswing Aug. 19 at 4:53 PM
$PFE not too bad for 2 days!
0 · Reply
BaronInvestments
BaronInvestments Aug. 19 at 4:36 PM
$PFE Argentina is becoming an important regional hub for Cellgenic, supporting biologics distribution, physician education and future expansion throughout Latin America.
0 · Reply
WuTangClam
WuTangClam Aug. 19 at 4:29 PM
$PFE this will be a 100$ stock within next few years with AI advancement. They are just like $MRNA , pfe will have its day.. stay long
0 · Reply
ccoccocco
ccoccocco Aug. 19 at 4:18 PM
$PFE does pfe have any pipeline for mrna cancer vaccine?
1 · Reply
INEEDMONEY87
INEEDMONEY87 Aug. 19 at 4:16 PM
$PFE still thinking we retest that 28.75
0 · Reply
HansFalsch
HansFalsch Aug. 19 at 4:16 PM
$PFE What’s BioNTech up to these days?
0 · Reply
GoforProMIS
GoforProMIS Aug. 19 at 4:13 PM
$PMN IMO we have 5-12 pharmaceutical companies interested in PMN: $BIIB /Eisai due to high Aria of Leqembi. $RHHVF as the lost bn with Gantenerumab and need a solution. Abbvie, Bristol Myers, Novartis are keen to get into neurology as partnership. $PFE and Takeda looking for Episelect Platform! CEO Neil Warma attended and presented at Jefferies Heathcare, Oppenheimer CNS and at the Bio International Conference with the opportunity of 1to1 meetings. As the Alzheimer Conference took place on on 12-15 July the 4-6 week NDA analyses by the specialist of pharmaceutical companies should be done.
0 · Reply
LLLJJJ
LLLJJJ Aug. 19 at 3:56 PM
$PFE 2 Days gap-up, should i sell ??
1 · Reply
Maine21
Maine21 Aug. 19 at 3:48 PM
$PFE just keep on paying those dividends and I’ll keep hanging around!! Lol…
1 · Reply
Hjaelmarsson
Hjaelmarsson Aug. 19 at 3:42 PM
$PFE Earnings were great and what a nice sp move lately of this dividend machine, best diversification to the AI/semi sector
0 · Reply
Orchard
Orchard Aug. 19 at 3:40 PM
Insiders buying or selling leading up to this? You all know they know the real story and it looks like they were selling and NOT BUYING. So f you were really curing cancer wouldn’t you be mortgaging your house to add to your position? $MRNA Watch these guys dump their shrs now. I trust Strip Club $RICK over these Big Pharma guys who can’t keep asbestos out of baby powder and skin cancer causing chemicals out of SUN SCREENS $JNJ (I’m talking to you) $PFE Lipitor cholesterol scam
1 · Reply